Investor’s Business Daily finds leading sectors with top stocks holding coveted spots on the IBD Sector Leaders list. Two of these three sector leaders are due to report at the end of January and are all worth watching.
How to make grades to start the new year super microcomputer (SMCI), KLA (KLAC) and IBD 50 strains Catalytic drug (CPRX).
Cloud storage stocks see big earnings growth in 2023
Super Micro Computer manufactures server and storage products for artificial intelligence, 5G and cloud computing.
The company plans to report earnings for the second quarter of fiscal 2023 in the last week of January. FactSet forecasts his earnings per share at $2.73, up significantly from last year’s 88 cents, but his staggering figure of $3.42 reported in the first quarter of 2023. is below
Revenue for the quarter is projected to be $1.73 billion, down from $1.85 billion in the previous quarter but well above the $1.17 billion reported in the second quarter of 2022.
SMCI shares are extending from the cup-based 5% buy zone at 75.03 buy points. The stock has been trading choppy since the breakout.
Chip equipment inventory forecasts further sales growth
KLA provides process control and solutions for the semiconductor and electronics industries. The company plans to report earnings on January 26.
FactSet forecasts second-quarter EPS of $7.10, up from $5.81 last quarter and $5.59 last year. Quarterly EPS growth has been impressive, ranging from 33% to 52% over the last three reporting periods. Annual EPS is expected to grow by 16% in 2023, but decline by 28% in 2024.
Revenue is projected to be $2.8 billion, up about 3% from the previous quarter and up 19% from the year-ago quarter. Quarterly sales growth has been consistent, ranging from 27% to 31% over the past three quarters.
KLAC shares edged above the 21-day exponential moving average on Friday on a day of strong technology-driven rally.
Catalyst Pharmaceuticals makes a drug for a rare autoimmune disorder called Lambert-Eaton Myasthenia Syndrome (LEMS).
The company’s fourth quarter 2022 earnings report won’t be released until March.
FactSet is targeting quarterly earnings of 20 cents per share. That’s down from 26 and 28 cents in the last two quarters. Quarterly EPS growth is solid, ranging from 64% to 86% over the last three reporting periods.
Quarterly revenue is projected to be $56.8 million, slightly down from $57.2 million in the third quarter, but higher than the $53.1 million in the second quarter.
You may also like:
Get Free IBD Newsletter: Market Readiness | Technical Report | How to Invest
What is CAN SLIM?If you want to find a winning stock, you better know it
IBD Live: Learn and analyze growth strains with the pros
Looking for the next big stock market winner? Get started with these 3 steps
Need more IBD insights? Subscribe to our investment podcast